We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

17 hedge funds and large institutions have $1.49M invested in Sonoma Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$334K +$515K +144 New
BIT
2
BlackRock Institutional Trust
California
$311K +$479K +134 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$298K +$458K +128 New
BA
4
Bard Associates
Illinois
$174K +$268K +75 New
BIM
5
Bogle Investment Management
Massachusetts
$154K +$239K +67 New
BRWA
6
B. Riley Wealth Advisors
Florida
$112K +$172K +48 New
RCM
7
Rotella Capital Management
Washington
$28K +$42.9K +12 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$23K +$35.7K +10 New
TRCT
9
Tower Research Capital (TRC)
New York
$20K +$28.6K +8 New
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$11K +$17.9K +5 New
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$9K +$14.3K +4 New
U
12
UBS
Switzerland
$6K +$7.15K +2 New
OWP
13
Obermeyer Wealth Partners
Colorado
$4K +$7.15K +2 New
Wells Fargo
14
Wells Fargo
California
$3K +$3.57K +1 New
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$2K +$3.57K +1 New
PFO
16
Pathstone Family Office
New Jersey
$2K +$3.57K +1 New
CCM
17
Chilton Capital Management
Texas
$1K +$3.57K +1 New

SNOA Hedge Fund Activity: Q2 2013 in Review

17 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q2 2013, worth a combined $1.49M.

Buyers outnumbered sellers: 17 funds opened new SNOA positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

  • 17 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.49M of Sonoma Pharmaceuticals stock for Q2 2013.
  • 17 funds opened new Sonoma Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +17 holders.

Based on aggregated 13F filings for Q2 2013.